Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

23 (9%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
OCTREOTIDE FOR INJECTABLE SUSPENSION 10MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-04-29 166969
OCTREOTIDE FOR INJECTABLE SUSPENSION 20MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-04-29 166972
OCTREOTIDE FOR INJECTABLE SUSPENSION 30MG POWDER FOR SUSPENSION, SUSTAINED-RELEASE KIT Actual shortage 2022-08-18 2024-04-29 166975
TEVA-TADALAFIL 5MG TABLET Resolved 2024-03-28 2024-04-25 223859
TEVA-TELMISARTAN 80MG TABLET Resolved 2024-01-11 2024-04-25 215728
TEVA-TELMISARTAN 40MG TABLET Resolved 2023-07-20 2024-04-25 199393
TEVA-FLUVASTATIN 20MG CAPSULE Resolved 2023-11-03 2024-04-25 209111
TEVA-BETAHISTINE 24MG TABLET Resolved 2024-02-01 2024-04-25 218129
TEVA-OLANZAPINE 5MG TABLET Resolved 2024-03-28 2024-04-25 223844
TEVA-SERTRALINE 100MG CAPSULE Resolved 2024-03-21 2024-04-25 222938
TEVA-NAPROXEN 500MG TABLET Resolved 2024-02-01 2024-04-25 218123
TEVA-CEPHALEXIN 250 250MG POWDER FOR SUSPENSION Resolved 2023-08-03 2024-04-25 200864
ACT DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2024-01-25 2024-04-25 217240
ACT DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2024-02-01 2024-04-25 218145
TEVA-TADALAFIL 2.5MG TABLET Actual shortage 2024-04-25 2024-04-25 226177
TEVA-BUSPIRONE 10MG TABLET Actual shortage 2024-04-25 2024-04-25 226174
TEVA-ECTOSONE 0.1% LOTION Actual shortage 2024-04-25 2024-04-25 226171
TEVA-MOMETASONE 50MCG SPRAY, METERED DOSE Actual shortage 2024-01-11 2024-04-25 215760
TEVA-DULOXETINE 30MG CAPSULE (DELAYED RELEASE) Actual shortage 2024-01-11 2024-04-25 215751
TEVA-BUPRENORPHINE/NALOXONE 2MG 0.5MG TABLET Actual shortage 2024-03-07 2024-04-25 221534

Showing 1 to 20 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81344
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81337
HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION Discontinued 2019-04-11 2019-04-11 81330
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
TEVA-PAROXETINE 10MG TABLET Discontinued 2019-04-11 2019-04-11 81313
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
TEVA-DILTIAZEM CD 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2019-04-11 2019-04-11 81307
TEVA-RANITIDINE SOLUTION 15MG SOLUTION Discontinued 2019-04-11 2019-04-11 81304
TEVA-LISINOPRIL/HCTZ (TYPE P) 12.5MG 20MG TABLET Discontinued 2019-04-11 2019-04-11 81301
TEVA-LISINOPRIL (TYPE P) 5MG TABLET Discontinued 2019-04-11 2019-04-11 81298
ACT ETIDROCAL 400MG 500MG TABLET Discontinued 2019-02-21 2019-03-01 76486
ACT OXYCODONE CR 5MG TABLET (EXTENDED-RELEASE) Discontinued 2018-10-22 2018-10-22 65328
ACT VENLAFAXINE XR 150.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65305
ACT VENLAFAXINE XR 37.5MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65298
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65295
ACT VENLAFAXINE XR 75.0MG CAPSULE (EXTENDED RELEASE) Discontinued 2018-10-22 2018-10-22 65292
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65289
ACT TADALAFIL Discontinued 2018-10-22 2018-10-22 65284
ACT ZOPICLONE 7.5MG TABLET Discontinued 2018-10-22 2018-10-22 65218

Showing 141 to 160 of 250